Information  X 
Enter a valid email address

Hikma Pharm PLC Ord Shs 10P (HIK)

Date Time Source Announcement
16 Oct 2018 4:30 pm
RNS
Block listing Interim Review
01 Oct 2018 10:53 am
RNS
Total Voting Rights
  10:23 am
RNS
Holding(s) in Company
03 Sep 2018 11:05 am
RNS
Total Voting Rights
30 Aug 2018 9:58 am
RNS
Holding(s) in Company
28 Aug 2018 12:45 pm
RNS
Holding(s) in Company
22 Aug 2018 9:41 am
RNS
Director/PDMR Shareholding
15 Aug 2018 7:00 am
RNS
Half-year Report
23 Jul 2018 9:00 am
RNS
Notice of Results
09 Jul 2018 9:00 am
RNS
Hikma enters licensing partnership with Perrigo
02 Jul 2018 4:56 pm
RNS
Total Voting Rights
15 Jun 2018 3:24 pm
RNS
Director/PDMR Shareholding
08 Jun 2018 11:50 am
RNS
Director/PDMR Shareholding
04 Jun 2018 10:29 am
RNS
Director/PDMR Shareholding
  9:00 am
RNS
Hikma appoints Chief Transformation Officer
01 Jun 2018 11:34 am
RNS
Total Voting Rights
30 May 2018 3:20 pm
RNS
Director/PDMR Shareholding
  9:00 am
RNS
Hikma launches Methylergonovine Maleate Tablets
23 May 2018 10:20 am
RNS
Director/PDMR Shareholding
18 May 2018 1:01 pm
RNS
AGM Results
  7:00 am
RNS
Trading Statement
17 May 2018 1:45 pm
RNS
Director/PDMR Shareholding
  1:10 pm
RNS
Director/PDMR Shareholding
15 May 2018 2:26 pm
RNS
Director/PDMR Shareholding
03 May 2018 9:00 am
RNS
Hikma launches Methotrexate Injection
01 May 2018 1:38 pm
RNS
Total Voting Rights
26 Apr 2018 1:40 pm
RNS
Holding(s) in Company
25 Apr 2018 10:41 am
RNS
Block listing Interim Review
24 Apr 2018 9:00 am
RNS
Hikma expands licensing agreement with Rovi
20 Apr 2018 9:00 am
RNS
Hikma launches Dexrazoxane for Injection
19 Apr 2018 12:00 pm
RNS
Annual Financial Report and Notice of AGM
10 Apr 2018 2:34 pm
RNS
Director/PDMR Shareholding
03 Apr 2018 11:19 am
RNS
Total Voting Rights
29 Mar 2018 9:00 am
RNS
Hikma launch-Palonosetron Hydrochloride Injection
20 Mar 2018 9:00 am
RNS
Hikma has launched Ritonavir Tablets USP
19 Mar 2018 3:50 pm
RNS
Director/PDMR Shareholding
14 Mar 2018 7:00 am
RNS
Final Results
12 Mar 2018 7:00 am
RNS
Update status on ANDA for generic Advair Diskus?
09 Mar 2018 9:21 am
RNS
Block Listing Application
27 Feb 2018 12:23 pm
RNS
Notice of Results
20 Feb 2018 7:00 am
RNS
Sigurdur Olafsson appointed CEO of Hikma
13 Feb 2018 4:43 pm
RNS
Holding(s) in Company
  4:43 pm
RNS
Holding(s) in Company
08 Feb 2018 12:41 pm
RNS
Director/PDMR Shareholding
  12:39 pm
RNS
Director/PDMR Shareholding
  12:37 pm
RNS
Director/PDMR Shareholding
26 Jan 2018 4:56 pm
RNS
Holding(s) in Company
  4:56 pm
RNS
Holding(s) in Company
17 Jan 2018 5:22 pm
RNS
Holding(s) in Company
  5:22 pm
RNS
Holding(s) in Company
15 Jan 2018 8:00 am
RNS
Hikma Appoints Dr. Surendera Tyagi
04 Jan 2018 11:19 am
RNS
Total Voting Rights
19 Dec 2017 9:00 am
RNS
Hikma reaches licensing agreement with Celltrion
13 Dec 2017 9:00 am
RNS
Hikma- Dihydroergotamine Mesylate Injection, USP
12 Dec 2017 9:59 am
RNS
Holding(s) in Company
  9:59 am
RNS
Holding(s) in Company
11 Dec 2017 9:33 am
RNS
Holding(s) in Company
01 Dec 2017 9:28 am
RNS
Total Voting Rights
30 Nov 2017 5:47 pm
RNS
Hikma Ventures- $20.5m Series C round for Prognos
28 Nov 2017 10:24 am
RNS
Announcement
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t